Prognostic Impact of AF Diagnosis-to-Ablation Time on Outcomes Following Catheter Ablation in AF and Left Ventricular Systolic Dysfunction
L. Segan(Baker Heart and Diabetes Institute), S. Prabhu(Baker Heart and Diabetes Institute), P. Kistler, H. Sugumar(Baker Heart and Diabetes Institute), Jeremy William(Baker Heart and Diabetes Institute), Rachel Crowley(St. Vincent's University Hospital), Lan Ling(Guangxi Medical University), Kevin Cho(Washington University in St. Louis), P. Sanders(Royal Adelaide Hospital), J. Morton(The Royal Melbourne Hospital), D. Chieng(Baker Heart and Diabetes Institute), A. Voskoboinik(Baker Heart and Diabetes Institute), J. Hawson(The Royal Melbourne Hospital), J. Kálmán(The Royal Melbourne Hospital), Geraldine Lee(University College Cork)
Cited by 0
Related Papers
Catheter Ablation of Atrial Fibrillation in Patients With Left Ventricular Systolic Dysfunction
|Circulation Arrhythmia and Electrophysiology|2014|173
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period
|Calcified Tissue International|2019|160
Immunomodulatory Layered Double Hydroxide Nanoparticles Enable Neurogenesis by Targeting Transforming Growth Factor-β Receptor 2
|ACS Nano|2021|128
The Seattle Criteria increase the specificity of preparticipation ECG screening among elite athletes
|British Journal of Sports Medicine|2013|123